These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9713726)

  • 1. A second-generation blood substitute (perfluorodichlorooctane emulsion) does not activate complement during an ex vivo circulation model of bypass.
    Rosoff JD; Soltow LO; Vocelka CR; Schmer G; Chandler WL; Cochran RP; Kunzelman KS; Spiess BD
    J Cardiothorac Vasc Anesth; 1998 Aug; 12(4):397-401. PubMed ID: 9713726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A perfluorocarbon emulsion prime additive improves the electroencephalogram and cerebral blood flow at the initiation of cardiopulmonary bypass.
    Vocelka C; Spiess B; Soltow L; Thomas R; Gohra H; Akimoto H; Rothnie C; Kunzelman K; Verrier E; Cochran RP
    J Extra Corpor Technol; 1995 Mar; 27(1):6-10. PubMed ID: 10150757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiopulmonary bypass circuit treated with surface-modifying additives: a clinical evaluation of blood compatibility.
    Gu YJ; Boonstra PW; Rijnsburger AA; Haan J; van Oeveren W
    Ann Thorac Surg; 1998 May; 65(5):1342-7. PubMed ID: 9594864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in platelet, granulocyte, and complement activation during cardiopulmonary bypass using heparin-coated equipment.
    Fukutomi M; Kobayashi S; Niwaya K; Hamada Y; Kitamura S
    Artif Organs; 1996 Jul; 20(7):767-76. PubMed ID: 8828766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of complement activation during bypass by prime manipulation.
    Bonser RS; Dave JR; Davies ET; John L; Taylor P; Gaya H; Lennox SC; Vergani D
    Ann Thorac Surg; 1990 Feb; 49(2):279-83. PubMed ID: 2306150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of biocompatibility between the open circuit and closed circuit in cardiopulmonary bypass.
    Nishida H; Aomi S; Tomizawa Y; Endo M; Koyanagi H; Nojiri C; Oshiyama H; Kido T; Yokoyama K
    Artif Organs; 1999 Jun; 23(6):547-51. PubMed ID: 10392283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of methylprednisolone on complement activation during heparin neutralization.
    Loubser PG
    J Cardiovasc Pharmacol; 1997 Jan; 29(1):23-7. PubMed ID: 9007666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perfluorocarbon oxygen transport. A comparative study of four oxygenator designs.
    Ferguson ER; Clymer JJ; Spruell RD; Holman WL
    ASAIO J; 1994; 40(3):M649-53. PubMed ID: 8555594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activation during cardiopulmonary bypass: effects of immobilized heparin.
    Pekna M; Hagman L; Haldén E; Nilsson UR; Nilsson B; Thelin S
    Ann Thorac Surg; 1994 Aug; 58(2):421-4. PubMed ID: 8067842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pressure drop, shear stress, and activation of leukocytes during cardiopulmonary bypass: a comparison between hollow fiber and flat sheet membrane oxygenators.
    Gu YJ; Boonstra PW; Graaff R; Rijnsburger AA; Mungroop H; van Oeveren W
    Artif Organs; 2000 Jan; 24(1):43-8. PubMed ID: 10677156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limitation of complement activation by perfluorocarbon emulsions: superiority of lecithin-emulsified preparations.
    Hammerschmidt DE; Vercellotti GM
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):431-8. PubMed ID: 3263156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement activation during cardiopulmonary bypass. Comparison of bubble and membrane oxygenators.
    Cavarocchi NC; Pluth JR; Schaff HV; Orszulak TA; Homburger HA; Solis E; Kaye MP; Clancy MS; Kolff J; Deeb GM
    J Thorac Cardiovasc Surg; 1986 Feb; 91(2):252-8. PubMed ID: 3511328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro and clinical study of complement activation during cardiopulmonary bypass with reference to types of oxygenator, primed autologous blood and patient's factor].
    Oda K
    Nihon Kyobu Geka Gakkai Zasshi; 1991 Sep; 39(9):1703-11. PubMed ID: 1960449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental studies of the influence of priming solutions on the systemic activation of complement during cardiopulmonary bypass: comparison between the use of albumin, hydroxyethyl starch and HWA-138.
    Bunk A; Dapper F; Hata H; Neuhof H; Hehrlein FW
    J Cardiovasc Surg (Torino); 1993 Apr; 34(2):115-22. PubMed ID: 7686550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in blood activation related to roller/centrifugal pumps and heparin-coated/uncoated surfaces in a cardiopulmonary bypass model circuit.
    Moen O; Fosse E; Bråten J; Andersson C; Høgåsen K; Mollnes TE; Venge P; Kierulf P
    Perfusion; 1996 Mar; 11(2):113-23. PubMed ID: 8740352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-coated cardiopulmonary bypass circuits in coronary bypass surgery.
    Horimoto H; Kondo K; Asada K; Sasaki S
    Artif Organs; 1996 Aug; 20(8):936-40. PubMed ID: 8853810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of autologous blood as part of the perfusate for cardiopulmonary bypass: a priming technique.
    Myers GJ; Legare JF; Sullivan JA; Leadon RB; Johnstone R; Swyer W; Squires C; Power C; Hirsch GM
    Perfusion; 2002 May; 17(3):211-6. PubMed ID: 12017390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations.
    Videm V; Svennevig JL; Fosse E; Semb G; Osterud A; Mollnes TE
    J Thorac Cardiovasc Surg; 1992 Apr; 103(4):806-13. PubMed ID: 1548925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood compatibility of two different types of membrane oxygenator during cardiopulmonary bypass in infants.
    Gu YJ; Boonstra PW; Akkerman C; Mungroop H; Tigchelaar I; Van Oeveren W
    Int J Artif Organs; 1994 Oct; 17(10):543-8. PubMed ID: 7896428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biocompatibility of heparin-coated membrane oxygenator during cardiopulmonary bypass.
    Hatori N; Yoshizu H; Haga Y; Kusama Y; Takeshima S; Segawa D; Tanaka S
    Artif Organs; 1994 Dec; 18(12):904-10. PubMed ID: 7887827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.